The role of ATP-sensitive potassium channel on acute urinary retention and subsequent catheterization in the rat
We investigated the role of K ATP channel on acute urinary retention (AUR) induced bladder dysfunction. Eight-week-old female Sprague–Dawley rats were divided into seven groups: a sham-operated control group, an AUR group, and five AUR groups treated with: two different K ATP channel openers namely...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2010-06, Vol.635 (1), p.194-197 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | We investigated the role of K
ATP channel on acute urinary retention (AUR) induced bladder dysfunction. Eight-week-old female Sprague–Dawley rats were divided into seven groups: a sham-operated control group, an AUR group, and five AUR groups treated with: two different K
ATP channel openers namely nicorandil (3 or 10
mg/kg), or cromakalim (100 or 300
μg/kg), or one K
ATP channel inhibitor namely glibenclamide (5
mg/kg). The drugs were administered 30
min before induction of AUR. After the urethra was obstructed with a clip, AUR was induced by intravesical infusion of 2.5
ml of saline via cystostomy. Following a 30
min obstruction the bladder was allowed to drain with a catheter in place for 60
min with real-time monitoring of intravesical pressure and blood flow. After the experimental period, the bladder function was assessed, using organ bath techniques (carbachol and 100
mM KCl). AUR increased the intravesical pressure and decreased the blood flow. The subsequent catheterization decreased the intravesical pressure and increased the blood flow. AUR group reduced significantly the contractile responses to both carbachol and KCl compared with the control group. Nicorandil and cromakalim but not glibenclamide prevented the bladder dysfunction after AUR suggesting that K
ATP channel openers may prevent the bladder dysfunction caused by AUR and subsequent catheterization. |
---|---|
ISSN: | 0014-2999 1879-0712 |
DOI: | 10.1016/j.ejphar.2010.02.052 |